M
echanisms that govern induction of a quiescent state, proliferation, and differentiation of primitive human hematopoietic progenitors, are not well understood. In vivo, hematopoiesis takes place in close proximity with the bone marrow microenvironment where hematopoietic stem cells reside, usually in Go, and occasionally proliferate and differentiate into more mature precursors. In vitro, this process is mimicked relatively closely in stroma-dependent, long-term bone marrow cultures (LTBMC) 1, originally described by Dexter et al. (1) . It is thought that proliferation of primitive 1 Abbreviations used in thispalx~ BM, bone marrow; CFC, colony-forming cell; IC, initiating cell; LDA, limiting dilution analysis; LIF, leukemia inhibitory factor; LTMBC, long-term bone marrow culture; MlP-lc~, macrophage inflammatory protein lcq rHu, recombinant human; SCF, stem cell factor. progenitors in these cultures is the result of the relative availability of both growth-promoting cytokines, which can be induced by a variety of stimuli, and the negative influence of growth inhibitory cytokines such as TGF-~ (2). However, human stroma-dependent LTBMC have a limited life span, and we and others (3, 4) have demonstrated that 70-80% of primitive progenitors capable of reinitiating secondary stromal cultures (LTBMC-initiating cell [IC] ) are lost over a period of 5 wk of culture.
We have recently developed an alternative long-term culture system in which hematopoietic progenitors are grown at a distance of the stromal layer in transwell inserts ("stromanoncontact" culture) (4, 5) . Cells in the transwell cannot physically interact with stromal cells present in the bottom well underneath the transweU, but diffusible factors can freely pass the 0.4-/~m filter membrane We have demonstrated that primitive CD34 +/DR-cells grown in such cultures can not only differentiate into committed progenitors and mature mydoid dements, but that significantly more LTBMC-IC can be recovered from these cultures than from stromal cultures in which the hematopoietic ceils are cultured in direct contact with the stromal layers. However, the recovery of LTBMC-IC at week 5 of culture is still not >50% of the originally seeded LTBMC-IC. To improve the recovery of LTBMC-IC in vitro, we have previously examined the effect of various, known growth-promoting cytokines, including IL-1, IL-3, IL-6, G-CSF, GM-CSF, leukemia inhibitory factor (LIF), and stem cell factor (SCF), on the recovery of LTBMC-IC from stromanoncontact cultures (5) . Although several of these cytokines improve the total cell expansion and production of committed progenitors in these cultures, none of the tested cytokines, either alone or in combination, were able to increase the number of LTBMC-IC present after 5 wk.
Macrophage inflammatory protein lot (MIP-lo 0' also termed stem cell inhibitor (6, 7) , is an 8-kD chemokine produced by macrophages, T lymphocytes, and bone marrow (BM) stromal cells (7) . MIP-la reversibly inhibits the proliferation of murine day 12-CFU-S and CFU-A both in vitro and in vivo (6, 8) . In humans, MIP-lol reversibly inhibits the proliferation of CFU-granulocyte, erythrocyte, macrophage, megakaryocyte (GEMM), burst forming unit-erythroid (BFU-E), and CFU-GM, whereas more mature CFU-E and single lineage CFU-G and CFU-M progenitors (9, 10) are stimulated. These studies suggest that MIP-lo~ may have an important role in maintaining immature hematopoietic progenitors in a quiescent state. Since loss of primitive progenitors from ex vivo long-term cultures may be the result of excessive stimulation of the usually quiescent primitive hematopoietic compartment resulting in their irreversible terminal differentiation, we elected to evaluate the effect of MIPlol on the recovery of immature LTBMC-IC from long-term stroma-noncontact cultures.
Materials and Methods

Cell Separations
BM was aspirated from the posterior iliac crest in heparin from healthy young volunteers after informed consent. Primitive CD34 +/HLA-DR-cells (DR-cells) were purified by sequential Ficoll-Hypaque centrifugation (s.g. 1077) (Sigma Chemical Co., St. Louis, MO), counterflow centrifugation elutriation (11, 12) , depletion oft lymphocytes and NK cens by sheep erythrocyte rosetting (13) , and depletion of committed lymphoid and mydoid/monocytic cells using immunomagnetic beads and anti-CD11b, anti-CD19 (Becton Dickinson & Co., Mountain View, CA), anti-MY8 (Coulter Cytometry, Hialeah, FL) and anti-glycophorin-A antibodies (AMAC, Inc., Westbrook, ME) (14) . The resultant lineage-negative cells were selected on a FACStar Plus | laser flow cytometry system (Becton Dickinson & Co.) equipped with a Consort 32 computer for low vertical and low horizontal light scatter properties and expression of CD34, but absence of HLA-DR antigens using mouse IgGI-PE and mouse IgG2a-FITC antibodies as controls (14) .
Long-term Culture Systems
Complete LTBMC media consisted of IMDM with 12.5 % FCS (Hyclone Laboratories, Logan, UT), 12.5% horse serum (Terry Fox Laboratories, Vancouver, Canada), 2 mM L-glutamine (GIBCO BRL, Gaithersburg, MD), 1,000 U/ml penicillin, 100 U/ml streptomycin (GIBCO BRL), and 10 .6 M hydrocortisone (14) . Conditioned Media Cultures. DR-cells (14,000 calls/well of 6-well plates) were plated in transwell inserts of stroma-free wells. Culture media for these cultures consisted of stroma-conditioned media obtained from "1"-150 flasks containing irradiated anogeneic stromal hyers. Media was transferred from the flask to the hematopoietic cell containing wells 2, 4, and 7 d after feeding the stromacontaining culture vessd. Upon transfer of the media from the T-150 flask, cytokines were added to obtain the final desired concentration.
Stroma-free Culture~
Maintenance of Cultures.
All cultures were maintained in a humidified atmosphere at 37~ and 5% CO2. At weekly intervals stroma-noncontact and stroma-free cultures were fed by removing half the call-flee media from the bottom wells only and replacing with fresh complete media. Conditioned media cultures received media conditioned by allogeneic irradiated stromal layers for 2, 4, or 7 d after f~eding.
Enumeration of Cell Number. Cells recovered from stroma-ffee, stroma-noncontact, or conditioned media cultures were recovered at week 1, 2, 3, 5, or 8 from the transwell inserts after vigorous washing. Calls were resuspended in IMDM plus 20% FCS, and an aliquot obtained for enumeration under hemocytometer.
Enumeration of Colon]t-forming Cell (CFC) by Met~lcellulose Cul-
ture. Cells harvested at week 1, 2, 3, or 5 from transwen inserts of stroma-noncontact cultures were plated in methylcellulose progenitor assay supplemented with 3 IU erythropoietin (Epoietin; Amgen Biologicals, Thousand Oaks, CA) and 5-10% 5637 bhdd~ carcinoma conditioned media as described (14) . The cultures were assessed at day 18 of culture for the presence of secondary CFC.
Enumeration of the Absolute Number of LTBMC-IC by Limiting Dilution Assays (LDA). At day 0, DR-cells (22 replicates per
concentration; 400, 150, 50, and 15 DR-cells/well) were plated onto 3 x 104 irradiated allogeneic stromal cells or irradiated M2-10134 murine stromal calls subcultured in 96-well plates. Likewise, cells recovered after 5 or 8 wk from stroma-noncontact cultures, stroma-free cultures, and conditioned media cultures initiated at day 0 with 13,530 DR-cells were plated in LDA (cell number is the equivalent of 400, 150, 50, and 15 DR-calls at day 0) as described (4) . In each experiment, day 0 LDAs and LDAs performed at weeks 5 and 8 with cultured cells, were always performed either on marrow stromal feeders or on M2-10B4 feeders. Cultures were maintained at 37~ and 5% COz in a humidified atmosphere for an additional 5 wk. At weekly intervals, 75 ~1 media was removed and replaced by 75 ml flesh complete media. At week 5, all media was removed and the stromal layers with hematopoietic cells overlaid with 200/~1 methylcelhlose media supplemented with 30% FCS, 5-10% supernatant of the bhdder cancer cell line 5637 and 3 IU erythropoietin. 2 wk later, wells were scored for the presence or absence of CFC as described (5) . The absolute number of LTBMC-IC present in the different cell populations was calcuhted as the reciprocal of the concentration of test cells that gives 37% negative cultures using the Poisson statistics (15) and the weighted mean method (16) .
Cytokines
Recombinant human (rHu) ID3 (Genetics Institute, Cambridge, MA) was added to cultures three times per week to obtain a final concentration of 5 ug/ml (as indicated in the Results section), rHu stem cell factor (SCF) (Amgen) was added to stroma-free cultures three times per week to obtain a final concentration of 20 ng/ml (as indicated in the Results section), rHuMIP-la (R.&D Systems, Inc., Minneapolis, MN) was added to cultures three times per week to obtain a final concentration of 10, 50, or 100 ug/ml as indicated (concentrations were based on studies demonstrating a growth inhibitory effect of 100 ug/ml MIP-la on committed human hematopoietic progenitors [9, 10] ). TGF-31 (R&D Systems, Inc.) was added once weekly 4 d after the regular feeding. Since cyclical proliferation of immature CFC in LTBMC is thought to be the result of increased production of growth-promoting factors early after feeding fonowed by the proliferation inhibitory effects of TGr'-3 in the second part of the week after feeding, we dected to add TGF-/~ 4 d after feeding only in association with IL-3 three times per week to mimic cytokine fluaes thought to induce cyclical proliferation of primitive CFC in LTBMC (2). were cultured in stroma-noncontact cultures supplemented without cytokines, MllXla (100 ng/ml, three times per week), IL-3 (5 ng/ml, three times per week), or 5 ng/nd IL-3 and 100 ng/ml MIlXla three times per week for 5 and 8 wk. Cens were collected from the transwell insert and enumerated under hemocytometer. Fold expansion was calculated as the number of cells present in transwell inserts at the different time points divided by the number of cells used to initiate the cultures. Differences between cytokine-free or MIP-la-supplemented cultures and either IL-3 or MIP-la+Ib3-supplemented cultures were significant at the <0.001 level (* *). Differences between cytokine-free and MIP-la-supplemented were not significant. Differences between IL-3 and MIP-la + II~3-supplemented cultures were not significant.
Stromal Layers
BMStromaiLayers. BM stromal layers were generated as previously described (15) . In short, BM mononuclear cells from normal individuals were suspended in complete LTBMC media and incubated for 4 d at 37~ in a humidified atmosphere with 5% CO2, and afterwards at 33~ Cultures were demipopulated weekly and media replaced with fresh complete media. Once confluent (3-5 wk after initiation of the culture) stromal layers were irradiated with 1,250 tad using a Mark-1 cesium irradiator (Shepard and Associates, Glendale, CA). Stromal layers were then subcultured in wells of 6-, 24-, or 96-well plates before use.
M2-10B4.
M2-10B4, a murine BM stroma cell line, was maintained in R.PMI-1640 supplemented with 10% FCS. M2-10B4 was subcultured in the wells of a 96-well phte (Costar Corp.). When confluent, plates were irradiated with 6,000 rad using a cesium irradiator, and all media replaced by complete LTBMC media. Irradiated plates were used 2-7 d hter. Several studies have demonstrated that maintenance of LTBMC-IC and their differentiation into CFC is similar when DR-cells are cultured either on BM stromal layers or on murine M2-10B4 feeders (3, 17) .
without MIP-la, IL-3, or MIP-la plus IL-3. Cell expansion was significantly greater in stroma-noncontact cultures supplemented with IL-3 alone or MIP-la+IL-3 than in cytokine-free cultures (Fig. 1) or cultures with MIP-la alone. Significantly more CFC were present in stroma-noncontact cultures supplemented with IL-3 or MIP-la+IL-3, 3 and 5 wk after initiation of the culture (Fig. 2 ) than in cytokinefree or MIP-la supplemented cultures. DR.-derived progeny, recovered 5 wk after initiation of the stroma-noncontact NO CYTOKINES
MIP-la
Statistics
Results of experimental points obtained from multiple experiments were reported as the mean + 1 SEM. Significance levels were determined by two-sided Student's t test analysis.
Results and Discussion
To determine if addition of MIP-la alone or in conjunction with factors with known growth-promoting activity to stroma-noncontact cultures could maintain a constant level of primitive human heraatopoietic progenitors in in vitro cultures, DK-cells, which contain the LTBMC-IC (14, 18) , and transplantable hematopoietic stem cells (19) , were cultured in stroma-noncontact cultures supplemented with or
200 400 600 $00 1000 1200 CFC / S,000 DR-CELLS Figure 2 . FACS ~ sorted DK-cells (n ffi 3) were cultured in stromanoncontact cultures supplemented without cytokineg MIP-la (100 ng/ml three times per week), II.,3 (5 ng/ml, three times per week), or II.~3 and MIP-la (5 and 100 ng/ml, three times per week) for 5 wk. Cens were collected from the transwell insert and replated in methylcelhlose progenitor culture (*). The cultures were assessed at day 18 of culture for the presence of secondary CFC as previously described (*). Comparison between cytokine-free and ID3-supplemented cultures: (*) p g0.01. Comparison between cytokine-free or MIP-la-supplemented cultures and MIPla + 1L3-supplemented cultures: (I) p <0.05. ~ces between cytokinefree and MIP-la-supplemented cultures were not significant. Differences between IL-3 and MIP-la+Ib3-supplemented cultures were not significant.
cultures, was also replated in LDA onto secondary stromal feeders to enumerate the absolute number of LTBMC-IC present in the transwe11 inserts. Approximately 50% of LTBMC-IC present in originally sorted DR-cells were still present at week 5 in cytokine-ffee stroma-noncontact cultures (Fig. 3) . Addition of MIP-lcx or IL3 alone to stromanoncontact cultures did not significantly change the number of LTBMC-IC present at week 5 compared to cytokine-ffee cultures. However, addition of the combination of MIP-lc~ +IL3 to stroma-noncontact cultures resulted in the recovery of 95-200% of the initially seeded LTBMC-IC after 5 wk of culture.
Whereas addition of early acting, growth-promoting cytokines, such as IL-3, LIF, G-CSF, or SCF to stromanoncontact cultures does not increase the recovery of LTBMC-IC, combined addition of supraphysiological amounts of these cytokines results in a significantly greater loss of primitive progenitors ow time (5) . This suggests that multiple cytokines may overwhelm the (ill-defined) antidifferentiation effect of stroma-derived factors and may result in irreversible differentiation of primitive progenitors. To determine ff continued presence of high concentrations of MIP-loc + IL-3 in stromanoncontact cultures would result in a similar exhaustion of the primitive LTBMC-IC pool, stroma-noncontact cultures with or without these cytokines were maintained for 8 wk before replating the DR-progeny in LDA onto secondary stromal feeders (Fig. 3) MIP-lot alone for 8 rather than 5 wk resulted in an ~60% loss of LTBMC-IC, which was not significantly different than that observed at week 5. Interestingly, culture of DR-cells in IL-3 supplemented stroma-noncontact cultures for 8 wk resulted in a significant depletion of LTBMC-IC (<5% of the originally sorted DR-population). However, combined addition of MIP-lot + IL-3 resulted in an imignificant decrease in LTBMC-IC number compared with week 5 and continued recovery of 80-150% of day 0 LTBMC-IC. We demonstrate that addition of 10, 50, or 100 ng/ml MIP-lex with IL-3 to stroma-noncontact cultures restdted in a similar recovery of LTBMC-IC (data not shown). These results are consistent with those described by Mantel et al. (20) who recently demonstrated that addition of MIP-lot at concentrations ranging from 10 to 500 ng/ml to methylcellulose cultures had equivalent effects on committed murine hematopoietic progenitor growth. The mechani.r through which MIP-lc~ + IL-3 in stromanoncontact cultures maintain primitive progenitors capable of reinitiating long-term cultures are unclear. Although the receptor for MIP-la has recently been identified as a seven tram-membrane spanning receptor bdongiag to the superfamily of G protein-linked receptors (21), the molecular mechanism(s) underlying the growth-modtdating effects of MIP-la are unknown. We hypothesize that the increased recovery of LTBMC-IC from cultures supplemented with MIP-la + IL-3 may be the result of an increased proliferation without terminal differentiation of LTBMC-IC. MIP-lc~ was originally described as "stem cell inhibitor" since it inhibits in vitro and in vivo proliferation of immature CFU-A, CFU-S, and CFU-GEMM progenitors (6-10). Our observations may, however, not be the result of growth inhibition. In contrast to the effect of MIP-lot + IL-3 on LTBMC-IC recovery, combined addition of TGF-~+IL-3 to stroma-noncontact cultures resulted in a decreased recovery of ceils (data not shown), CFC (data not shown), and LTBMC-IC after 5 wk of culture compared with cultures to which IL-3 alone was added (Fig. 4) . It is well known that TGF-15 inhibits cell proliferation by preventing their transition through the cell cycle (22, 23) . A direct antiproliferative effect of TGF-~ may therefore Figure 3 . Freshly sorted DR-cells were phted in limiting dilution on bone marrow stromal layers or M210-B4 feeders (22 replicates of 400, 150, 50, and 15 cells) for 5 wk (Day 0). 14,000 DR-calls were plated in stroma-noncontact cultures supplemented without cytokines, with MIP-la alone (100 ng/ml, three times per week), Ib3 (5 ng/ml, three times per week), or IL,3 and MIP-lr~ (5 and 100 ng/ml, three times per week) for 5 and 8 wk. Cells retorted from the transwell inserts were then replated in LDA on either bone marrow stromal layers or M210-B4 feeders for an additional 5 wk (cell number -the equivalent of 400, 150, 50, and 15 DR.-cells at day 0). After 5 wk, stromal hyers were overlayed with methylcellulose-containing media supplemented with erythmpoietin and supernatant from the bladder CA ceil line 5637, and wells were scored 2 wk hter for the presence or absence of CFC and the absohte number of LTBMC-IC present in the different cell populations calenhted (*). Comparison between day 0 and week 5 is noted above the week 5 bars. Comparison between weeks 5 and 8 is only significant for cultures supplemented with IL-3. (25) . To examine if stroma is required to maintain a constant number of LTBMC-IC for 5-8 wk in the presence of M1P-lcx + IL-3, DR-ceils were also cultured in "stromafree" cultures, in which DR-cells were suspended in transwell inserts placed in empty wells. These cultures were fed weekly with fresh complete media, not conditioned by stromal layers, and supplemented three times per week with MIP1r +IL-3+SCF. Only 5% of LTBMC-IC present at day 0 in freshly sorted DR-cells were recovered from stroma-free cultures supplemented with MIP-lc~ +IL-3+SCF (Fig. 5) , indicating that additional stroma-derived soluble factors are synergyzing with MIP-lc~ + IL-3 to maintain a constant level of human LTBMC-IC in in vitro cultures.
MIP-lc~ receptors are present on monocytes/macrophages (7) and MIP-lcx induces chemotaxis and oxidative burst in monocytes (26) . Observations described here could therefore be the result of the induction of secondary differentiationinhibitory or proliferation-inducing factors by stromal macrophages. Addition of MIP-lcx+IL-3 did, however, not significantly change the level of cytokines, including GM-CSF and IL-1/3, present in stromal supernatants, as determined by ELISA (data not shown). To examine ff the observed effects of MIP-lcx + IL-3 are the result of thdr direct interaction with hematopoietic progenitors or of an indirect effect on stromal cells, we cultured DR-ceils in LTBMC Figure 5 . 14,000 DR-ceils were phted in stroma-noncontact cultures supplemented with (*) or without MIP-lc~+Ib3 (I). Alternatively, 14,000 DR-cells were plated in stroma-free cultures supplemented with SCF (20 ng/ml three times per week) and IL-3 (5 ng/ml three times per week) and with Q) or without (*) MIP-la (100 ng/ml three times per week) for 5 wk. 14,000 DR-cells were also plated in conditioned media cultures. Cytokines were added to the conditioned media upon transfer from the stroma-containing T-150 flask to the DR-call-containing culture vessel to obtain the final desired concentration in those cultures with cytokines (I) (5 ng/ml Ib3 three times per week and 50 ng/ml MIP-ltx three times per week). Ceils recovered from the transweil inserts of all three culture systems were replated in LDA on either bone marrow stromal layers or M210-B4 feeders for an additional 5 wk (cell number ffi the equivalent of 400, 150, 50, and 15 DR-cells at day 0) and the absolute number of LTBMC-IC present in the different cell populations was calculated as described.
media conditioned by allogeneic stromal layers present in a separate culture vessel. MIP-lot + IL-3 was added to the conditioned media when transferred to the hematopoietic cell-containing well and was therefore never in contact with the stromal layer. Culture of DR-calls in conditioned media without cytokines results in maintenance of an equivalent number of LTBMC-IC as when cultured in stroma-noncontact cultures (Fig. 5) . When MIP-lcx + IL-3 were added to the conditioned media, a similar number of LTBMC-IC was present after 5 wk of culture compared with that in MIP-lot + IL-3 conraining stroma-noncontact cultures (Fig. 5 ). This suggests that MIP-lot +IL-3 exert their effect through direct interaction with DR-cells or their progeny rather than through altering the bone marrow microenvironment milieu. We demonstrate for the first time that at least 100% of LTBMC-IC can be maintained in vitro for a minimum of 2 mo when cultured in the presence of MIP-lol +IL-3 in stroma-noncontact cultures. MIP-lc~ + IL-3 require additional undefined diffusible factors from stroma to maintain a constant number of LTBMC-IC for 5-8 wk in culture. The effect of MIP-lot +IL-3 is, moreover, the result of the direct interaction of MIP-lot +IL-3 with the DR-cell population or its progeny, but not with the stromal layer. It remains to be seen if the addition of other carly-acting, growth-promoting cytokines, such as IL-6 (11), IL-11 (27) , LIF (28) , SCF (29) , or G-CSF (30) , to the combination of MIP-lot, IL-3, and stroma-derived factors will further expand the human primitive progenitor compartment ex vivo, but not trigger the primitive cell compartment into irreversible terminal differentiation. The observation that a constant level of very primitive LTBMC-IC can be maintained for at least 8 wk in ex vivo cultures when grown in the presence of MIP-lc~, IL-3, and stroma-derived soluble factors suggests a possible clinical application for such culture systems for in vitro stem cell expansion and retroviral gene transfection protocols.
